Mark J. Newman - 17 Jun 2026 Form 4 Insider Report for GeoVax Labs, Inc. (GOVX)

Reporting relationship
Chief Scientific Officer
Issuer ticker
GOVX
Reported as of
17 Jun 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
22 Jun 2026, 16:18:01 UTC
Prior SEC filing
06 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark J. Newman

Key filing fact

Mark J. Newman filed Form 4 for GeoVax Labs, Inc. (GOVX) on 22 Jun 2026.

Key facts

  • This page summarizes Mark J. Newman's Form 4 filing for GeoVax Labs, Inc. (GOVX).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 22 Jun 2026, 16:18.

Change

  • Previous filing in this sequence was filed on 06 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001242123 Primary reporting owner

NEWMAN MARK J

Relationship
Chief Scientific Officer
Address
1955 LAKE PARK DRIVE, SUITE 380, SMYRNA
Signature
/s/ Mark J. Newman
Signature date
19 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GOVX transaction Derivative

Stock Option

Award

Transaction value
Shares
+17,600
Change %
Price
$0.000000*
Shares after
17,600
Date
17 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,600
Exercise price
$1.18
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .